Cargando…
Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells
Oncolytic viruses (OVs) are an emerging class of anti-cancer agents that replicate selectively within malignant cells and generate potent immune responses. Their potential efficacy has been shown in clinical trials, with talimogene laherparepvec (T-VEC or IMLYGIC(®)) now approved both in the United...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402671/ https://www.ncbi.nlm.nih.gov/pubmed/34452316 http://dx.doi.org/10.3390/v13081450 |